daunorubicin has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 26 (83.87) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Boustani, H; Ghotaslou, A; Kiani Ghalesardi, O; Kiani, J; Rezvani, MR; Shahidi, M; Zaker, F | 1 |
| Kapoor, R; Rastogi, N; Sarma, S; Thakkar, D; Wadhwa, T; Yadav, SP | 1 |
| Du, S; Du, X; He, C; Jia, P; Li, J; Lu, H; Shen, Z; Tong, J; Wu, Y; Xu, H; Zhao, W; Zhou, L | 1 |
| Basso, G; Biondi, A; Buldini, B; Cazzaniga, G; Conter, V; Grillo, MF; Paganin, M; Scapinello, G; Silvestri, D; Te Kronnie, G; Valsecchi, MG | 1 |
| Fuhrmann, S; Karawajew, L; Kulozik, AE; Kunz, JB; Ludwig, WD; Möricke, A; Ratei, R; Schabath, R; Schrappe, M; Zimmermann, M | 1 |
| Li, J; Meng, QH | 1 |
| Bandapalli, OR; Biecek, P; Dawidowska, M; Drobna, M; Jaksik, R; Kosmalska, M; Kowalczyk, JR; Kraszewska-Hamilton, M; Kulozik, AE; Kunz, JB; Sędek, Ł; Szarzyńska-Zawadzka, B; Szczepański, T; Van Vlierberghe, P; Witt, M; Zdon, K | 1 |
| Penning, TM; Trippier, PC; Verma, K; Zang, T | 1 |
| Eckert, C; Henze, G; v Stackelberg, A | 1 |
| Karawajew, L; Ludwig, WD; Möricke, A; Ratei, R; Schabath, R; Schrappe, M; Zimmermann, M | 1 |
| Chung, NG; Jang, W; Kim, M; Lee, JW | 1 |
| Behulova, D; Bernatikova, H; Chocholova, A; Demlova, R; Mikuskova, A; Mladosievicova, B; Mrkvicova, M; Pilatova, K; Soltysova, A; Stary, J; Sterba, J; Sukova, M; Valik, D; Zdrazilova-Dubska, L | 1 |
| Baytan, B; Bengoa, SY; Evim, MS; Gözmen, S; Güneş, AM; Irken, G; Karapınar, TH; Oren, H; Tüfekçi, O | 1 |
| Devidas, M; Gaynon, PS; Hastings, C; Lu, X; Nachman, JB; Sather, HN; Seibel, NL | 1 |
| Deng, L; Lin, N; Liu, W; Ping, L; Song, Y; Tu, M; Wang, X; Xie, Y; Ying, Z; Zhang, C; Zhang, Y; Zheng, W; Zhu, J | 1 |
| Abnous, K; Danesh, NM; Lavaee, P; Ramezani, M; Taghdisi, SM | 1 |
| Araújo, AG; Covas, DT; Dalmazzo, LF; Fráguas, MS; Haddad, R; Lucena-Araujo, AR; Oliveira, LH; Panepucci, RA; Rego, EM; Schiavinato, JL; Zago, MA | 1 |
| Hirano, T; Nakaoka, E; Onda, K; Sugiyama, K; Tanaka, S | 1 |
| Aref, S; El Menshawy, N; El-Baiomy, MA; El-Ghonemy, MS; Zeid, TA | 1 |
| Beverloo, HB; Cornelissen, JJ; Deenik, W; Valk, PJ; van der Poel-van de Luytgaarde, SC; van Esser, JW; Wattel, MM | 1 |
| Breit, S; Danckwardt, S; Kulozik, AE; Liu, S; Muckenthaler, MU | 1 |
| Arima, K; Hasegawa, D; Hori, T; Hosoya, R; Imamura, T; Kato, I; Kitagawa, Y; Manabe, A; Ogawa, C; Takahashi, H; Takusagawa, A; Tsurusawa, M | 1 |
| Attarbaschi, A; Dworzak, M; Gadner, H; Haas, OA; Inthal, A; Janousek, D; Mann, G; Panzer-Grümayer, R; Pisecker, M; Pötschger, U; Schrappe, M; Strehl, S; Ullmann, R | 1 |
| Henmi, K; Hirano, T; Ishii, K; Kagami, K; Kaise, T; Tanaka, S; Toyoda, H | 1 |
| Abnous, K; Behravan, J; Mosaffa, F; Taghdisi, SM | 1 |
| Cai, Y; Ling, JY; Sun, XF; Xia, Y; Yan, SL; Zhen, ZJ | 1 |
| Ciofani, T; Fan, M; Harasym, TO; Huang, R; Lim, WS; Mayer, LD; Tardi, PG; Xie, X | 1 |
| Attarbaschi, A; Beier, R; Lauten, M; Meissner, B; Möricke, A; Niemeyer, C; Niggli, F; Odenwald, E; Riehm, H; Schrappe, M; Stanulla, M; Zimmermann, M | 1 |
| Andres, CR; Benz-de Bretagne, I; Gendrot, C; Jonville-Bera, AP; Jourdain, A; Le Guellec, C; Tarfaoui, N | 1 |
| Gale, RE; Goulden, N; Hancock, J; Jenkinson, S; Koo, K; Linch, DC; Mansour, MR; Mitchell, C; Moorman, AV; Richards, S; Vora, A; Wade, R | 1 |
| Ayed, S; Bouguila, H; Bouladi, M; Chebbi, A; Nacef, L; Taamallah-Malek, I | 1 |
1 review(s) available for daunorubicin and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
[Massive bilateral subconjunctival hemorrhage revealing acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Emergencies; Eye Hemorrhage; Fever; Gingival Hemorrhage; Humans; Male; Methotrexate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Purpura; Young Adult | 2013 |
6 trial(s) available for daunorubicin and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; CD13 Antigens; CD56 Antigen; Child; Daunorubicin; Humans; Immunophenotyping; Neoplasm, Residual; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Sialic Acid Binding Ig-like Lectin 3; Survival Analysis; Vincristine | 2018 |
PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Male; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; PTEN Phosphohydrolase; Survival Rate; Vincristine | 2019 |
Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Lineage; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Flow Cytometry; Humans; Immunophenotyping; Infant; Leukemia, Biphenotypic, Acute; Male; Mercaptopurine; Methotrexate; Neoplasm, Residual; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Analysis; Vincristine | 2013 |
Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukemia, B-Cell; Leukocyte Count; Leukocytosis; Male; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk; Treatment Outcome; Vincristine | 2015 |
Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Lymphocyte Count; Male; Mercaptopurine; Neoplasm, Residual; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Prospective Studies; Remission Induction; Risk Assessment; Treatment Outcome; Vincristine | 2012 |
Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cell Cycle Proteins; Child; Child, Preschool; Cohort Studies; Daunorubicin; Dexamethasone; DNA, Neoplasm; F-Box Proteins; F-Box-WD Repeat-Containing Protein 7; Female; Genotype; Humans; Infant; Male; Mutation; Polymerase Chain Reaction; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Receptor, Notch1; Remission Induction; Survival Rate; Ubiquitin-Protein Ligases; Vincristine; Young Adult | 2013 |
24 other study(ies) available for daunorubicin and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin.
Topics: Cell Cycle Proteins; Cell Line, Tumor; Daunorubicin; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Ribonucleotide Reductases; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2023 |
COVID-19 reinfection in two children with cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Child, Preschool; Cisplatin; COVID-19; Cyclophosphamide; Daunorubicin; Etoposide; Humans; Male; Neuroblastoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reinfection; SARS-CoV-2; Vincristine | 2021 |
Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Apoptosis; Bcl-2-Like Protein 11; Bortezomib; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Daunorubicin; Drug Synergism; Gene Expression; Humans; Jurkat Cells; Membrane Potential, Mitochondrial; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Gene Deletion; Humans; Male; Mutation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; PTEN Phosphohydrolase; Recurrence; Vincristine | 2018 |
A Patient with Severe Hyperkalemia.
Topics: Daunorubicin; Humans; Hyperkalemia; Male; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Renal Dialysis; Tumor Lysis Syndrome; Vincristine; Young Adult | 2018 |
Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Agents; Cell Line, Tumor; Cytarabine; Daunorubicin; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia, Myeloid, Acute; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Structure-Activity Relationship | 2019 |
ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Europe; Hematopoietic Stem Cell Transplantation; Humans; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retreatment; Survival Rate; Vincristine | 2013 |
Acute myeloid leukemia of mixed megakaryocytic and erythroid origin following chemotherapy for T-cell lymphoblastic lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Dexamethasone; Erythroid Cells; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Megakaryocytes; Mitoxantrone; Neoplasms, Second Primary; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine | 2014 |
Augmenting clinical interpretability of thiopurine methyltransferase laboratory evaluation.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chromatography, High Pressure Liquid; Cyclophosphamide; Cytarabine; Czech Republic; Daunorubicin; Erythrocyte Membrane; Female; Genetic Association Studies; Humans; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Methyltransferases; Polymerase Chain Reaction; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Slovakia; Vincristine | 2014 |
The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Evaluation; Follow-Up Studies; Humans; Immunophenotyping; Infant; Kaplan-Meier Estimate; Leukocyte Count; Mercaptopurine; Oncogene Proteins, Fusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Turkey; Vincristine | 2014 |
Outcomes of dose-adjusted Berlin-Frankfurt-Münster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Middle Aged; Neoplasm Staging; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2015 |
Targeted and controlled release delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer-modified gold nanoparticles.
Topics: Antibiotics, Antineoplastic; Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; Daunorubicin; Delayed-Action Preparations; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2015 |
Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.
Topics: Antigens, Neoplasm; Apoptosis; Cell Line, Tumor; Cell Proliferation; Class Ia Phosphatidylinositol 3-Kinase; Cyclin-Dependent Kinase 6; Daunorubicin; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA-Binding Proteins; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Humans; Jurkat Cells; MicroRNAs; Mixed Function Oxygenases; Myeloid Cell Leukemia Sequence 1 Protein; Oligonucleotide Array Sequence Analysis; Peroxidases; Phosphatidylinositol 3-Kinases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Receptors, Interleukin-1 | 2015 |
Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vitamin K 3; Vitamins | 2015 |
Clinicopathologic Effect of DNMT3A Mutation in Adult T-Cell Acute Lymphoblastic Leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Egypt; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Mutation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Sequence Analysis, DNA; Young Adult | 2016 |
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; Dasatinib; Daunorubicin; Granulocyte Colony-Stimulating Factor; Humans; In Situ Hybridization, Fluorescence; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neutropenia; Oncogene Proteins, Fusion; Peripheral Blood Stem Cell Transplantation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Splenic Rupture; Thiazoles; Vincristine; Young Adult | 2009 |
Downregulation of Notch signaling by gamma-secretase inhibition can abrogate chemotherapy-induced apoptosis in T-ALL cell lines.
Topics: Amyloid Precursor Protein Secretases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Asparaginase; Benzodiazepinones; Cell Line, Tumor; Daunorubicin; Dexamethasone; Down-Regulation; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Notch1; Signal Transduction; Vincristine | 2009 |
Detection of submicroscopic disease in the bone marrow and unaffected testis of a child with T-cell acute lymphoblastic leukemia who experienced "isolated" testicular relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Child; Combined Modality Therapy; Daunorubicin; Humans; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Orchiectomy; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Testicular Neoplasms; Testis; Vincristine | 2009 |
Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Austria; Child; Child, Preschool; Daunorubicin; Female; Homeodomain Proteins; Humans; In Situ Hybridization, Fluorescence; Infant; Male; Oncogene Proteins, Fusion; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Vincristine | 2010 |
Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Resistance, Neoplasm; Flavones; Flavonoids; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2010 |
Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Base Sequence; Cell Line, Tumor; Daunorubicin; Drug Delivery Systems; Flow Cytometry; Humans; Nucleic Acid Conformation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Spectrometry, Fluorescence | 2010 |
Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Antigens, CD7; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclin D3; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Remission Induction; Survival Rate; Transcription Factors; Vincristine; Young Adult | 2010 |
Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Chemistry, Pharmaceutical; Cytarabine; Daunorubicin; DNA-Binding Proteins; Dosage Forms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Flow Cytometry; Humans; Liposomes; Maximum Tolerated Dose; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?
Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autonomic Nervous System Diseases; Biological Transport; Child; Cholestasis; Cyclophosphamide; Cytochrome P-450 CYP3A; Daunorubicin; Drug Combinations; Drug Interactions; Facial Pain; Female; Humans; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nalbuphine; Neoplasm Proteins; Neuralgia; Penicillanic Acid; Piperacillin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Seizures; Tazobactam; Vincristine | 2012 |